EP0730604A4 - Surface membrane proteins and their effect on immune response - Google Patents

Surface membrane proteins and their effect on immune response

Info

Publication number
EP0730604A4
EP0730604A4 EP95901851A EP95901851A EP0730604A4 EP 0730604 A4 EP0730604 A4 EP 0730604A4 EP 95901851 A EP95901851 A EP 95901851A EP 95901851 A EP95901851 A EP 95901851A EP 0730604 A4 EP0730604 A4 EP 0730604A4
Authority
EP
European Patent Office
Prior art keywords
effect
immune response
membrane proteins
surface membrane
proteins
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP95901851A
Other languages
German (de)
French (fr)
Other versions
EP0730604A1 (en
Inventor
Carol Clayberger
Alan M Krensky
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Leland Stanford Junior University
Original Assignee
Leland Stanford Junior University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Leland Stanford Junior University filed Critical Leland Stanford Junior University
Publication of EP0730604A1 publication Critical patent/EP0730604A1/en
Publication of EP0730604A4 publication Critical patent/EP0730604A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966—Animal cells
    • G01N33/56977—HLA or MHC typing
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Urology & Nephrology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Food Science & Technology (AREA)
  • Virology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
EP95901851A 1993-11-10 1994-11-10 Surface membrane proteins and their effect on immune response Withdrawn EP0730604A4 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US15049393A 1993-11-10 1993-11-10
US150493 1993-11-10
PCT/US1994/012985 WO1995013288A1 (en) 1993-11-10 1994-11-10 Surface membrane proteins and their effect on immune response

Publications (2)

Publication Number Publication Date
EP0730604A1 EP0730604A1 (en) 1996-09-11
EP0730604A4 true EP0730604A4 (en) 1998-01-07

Family

ID=22534794

Family Applications (1)

Application Number Title Priority Date Filing Date
EP95901851A Withdrawn EP0730604A4 (en) 1993-11-10 1994-11-10 Surface membrane proteins and their effect on immune response

Country Status (5)

Country Link
EP (1) EP0730604A4 (en)
JP (1) JPH09508617A (en)
AU (1) AU1093995A (en)
CA (1) CA2176208A1 (en)
WO (1) WO1995013288A1 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7011834B1 (en) * 1987-01-30 2006-03-14 The Board Of Trustees Of Leland Stanford Junior University Immunomodulating dimers
US6162434A (en) * 1995-05-03 2000-12-19 Sangstat Medical Corporation Cytomodulating peptide for inhibiting lymphocyte activity
US6436903B1 (en) * 1996-05-22 2002-08-20 Stanford University (Board Of Trustees Of The Leland Standford Junior University) Immunomodulating compounds comprising d-isomers of amino acids
ES2193401T3 (en) * 1996-09-18 2003-11-01 Gerhild Wildner PEPTIDES SUITABLE AS A DIAGNOSTIC AGENT AND THERAPEUTIC AGENT FOR AUTOIMMUNITY DISEASES.
TR199902786T2 (en) 1997-04-11 2000-06-21 Sangstat Medical Corporation Streamline the cell structure of lipophilic peptides to streamline immune system activity and stop inflammation.
US6696545B1 (en) 1997-04-11 2004-02-24 Sangstat Medical Corporation Cytomodulating lipophilic peptides for modulating immune system activity and inhibiting inflammation
CA2474056A1 (en) 2002-01-24 2003-07-31 Sangstat Medical Corporation Combination therapy for treatment of hiv infection
US7498309B2 (en) 2003-11-29 2009-03-03 Sangstat Medical Corporation Pharmaceutical compositions for bioactive peptide agents

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993017699A1 (en) * 1992-03-02 1993-09-16 The Board Of Trustees Of The Leland Stanford Junior University Lymphocyte activity regulation by hla peptides

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993017699A1 (en) * 1992-03-02 1993-09-16 The Board Of Trustees Of The Leland Stanford Junior University Lymphocyte activity regulation by hla peptides

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO9513288A1 *

Also Published As

Publication number Publication date
CA2176208A1 (en) 1995-05-18
WO1995013288A1 (en) 1995-05-18
JPH09508617A (en) 1997-09-02
EP0730604A1 (en) 1996-09-11
AU1093995A (en) 1995-05-29

Similar Documents

Publication Publication Date Title
IL101690A0 (en) Antibodies and methods utilizing the same
EP0746621A4 (en) Expression of proteins on bacterial surface
GB9013410D0 (en) Polypeptide and its use
ZA955225B (en) Crucifer AFT proteins and uses thereof
AU7432891A (en) Isdn interface circuit and system using the same
AU9179591A (en) Modified hepatocytes and uses therefor
EP0730604A4 (en) Surface membrane proteins and their effect on immune response
ZA9410217B (en) Recombinant human thymopoietin proteins and uses therefor.
SG49843A1 (en) HTLV-I and HTLV-II peptide antigens and methods
IL109717A0 (en) Cell surface proteins and methods for the preparation and use thereof
ZA918423B (en) Proteins and nucleic acids.
AU6809594A (en) Colletotrichum and use thereof
HUP9801330A3 (en) Novel pka-binding proteins and uses thereof
ZA924023B (en) Peptides useful in regulating the immune and nervous systems
EP0450813A3 (en) Protein phosphatase inhibitor-1 gene and expression
IL118324A0 (en) Immunoregulatory polypeptide and its uses
GB9026822D0 (en) Protein assay method and kit
GB9010359D0 (en) Enzyme and its preparation
AU8603591A (en) Peptide and its use
GB9105446D0 (en) Proteins and nucleic acids
GB9310227D0 (en) Protein and dna
AU5939994A (en) Linear peptides and uses thereof
EP0857732A4 (en) Human pec-60-like protein and dna encoding the same
AU1040292A (en) Lolitrems - antibodies and assay techniques
SI0690916T1 (en) Pesticidal proteins and strains

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19960603

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE

A4 Supplementary search report drawn up and despatched

Effective date: 19971124

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 19990601